Kazia Therapeutics Limited Overview

Kazia Therapeutics Limited Research & Development

Research & Development expenses for KZIA.

Quarterly R&D Expenses

$4.90M

↑ 128.89% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$23.05M

↓ 6.19% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin